Cargando…
Advances and Perspectives in the Treatment of T-PLL
PURPOSE OF REVIEW: T cell prolymphocytic leukemia (T-PLL) is a rare mature T cell tumor. Available treatment options in this aggressive disease are largely inefficient and patient outcomes are highly dissatisfactory. Current therapeutic strategies mainly employ the CD52-antibody alemtuzumab as the m...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230055/ https://www.ncbi.nlm.nih.gov/pubmed/32034661 http://dx.doi.org/10.1007/s11899-020-00566-5 |